ROS-mediated MAPK activation aggravates hyperoxia-induced acute lung injury by promoting apoptosis of type II alveolar epithelial cells via the STAT3/miR-21–5p axis

Song Qin,Jun-Ya Liu,Xiao-Qin Wang,Bang-Hai Feng,Ying-Cong Ren,Jie Zheng,Kun Yu,Hong Yu,Kang Li,Feng Zhu,Miao Chen,Xiaoyun Fu,Tao Chen,Zhou-Xiong Xing,Hong Mei,Jun-ya Liu,Xiao-qin Wang,Bang-hai Feng,Ying-cong Ren,Zhou-xiong Xing
DOI: https://doi.org/10.1016/j.molimm.2023.09.016
IF: 4.174
2023-10-15
Molecular Immunology
Abstract:Inhibition of type II alveolar epithelial (AE-II) cell apoptosis is a critical way to cure hyperoxia-induced acute lung injury (HALI). It has been reported that miR-21–5p could reduce H 2 O 2 -induced apoptosis in AE-II cells. However, the upstream molecular mechanism remains unclear. Herein, we established a cellular model of HALI by exposing AE-II cells to H 2 O 2 treatment. It was shown that miR-21–5p alleviated H 2 O 2 -induced apoptosis in AE-II cells. ROS inhibition decreased apoptosis of H 2 O 2 -evoked AE-II cells via increasing miR-21–5p expression. In addition, ROS induced MAPK and STAT3 phosphorylation in H 2 O 2 -treated AE-II cells. MAPK inactivation reduces H 2 O 2 -triggered AE-II cell apoptosis. MAPK activation inhibits miR-21–5p expression by promoting STAT3 phosphorylation in H 2 O 2 -challenged AE-II cells. Furthermore, STAT3 activation eliminated MAPK deactivation-mediated inhibition on the apoptosis of AE-II cells under H 2 O 2 condition. In conclusion, ROS-mediated MAPK activation promoted H 2 O 2 -triggered AE-II cell apoptosis by inhibiting miR-21–5p expression via STAT3 phosphorylation, providing novel targets for HALI treatment.
biochemistry & molecular biology,immunology
What problem does this paper attempt to address?